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Abstract
Background: The mce operons play an important role in the entry of M. tuberculosis into macrophages and non-
phagocytic cells. Their non-redundant function as well as complex regulation is implied by the phenotype of mce 
mutants. Recently, mce1 operon was found to extend over 13 genes, fadD5 (Rv0166) being the first gene of the operon. 
The presence of a non-coding sequence of 200 base pairs between Rv0166 and Rv0167 is peculiar to mce1 among the 
four mce operons of M.tuberculosis. We have examined the function of this region.
Results: We predicted putative promoter activity of the 200 base pairs of non-coding, intergenic region between 
Rv0166 and Rv0167 in silico using MEME software and designate it as intergenic promoter, IGPr. We demonstrate both 
promoter activity and a putative negative regulatory function of this fragment by reporter assays carried out in the 
surrogate host M.smegmatis. We find that the repressive elements not only control the native promoter but also repress 
a heterologous promoter of M.smegmatis. The higher activity of the intergenic promoter in a clinical isolate in 
comparison with the wild type sequence from M.tuberculosis H37Rv could be correlated with a point mutation within 
the negative element. We have mapped two transcription start sites for mce1 operon both of which are utilized in 
M.tuberculosis H37Rv as well as the clinical isolate VPCI591. Our studies show that the promoter activity in the non-
coding region is relevant not only in reporter gene expression but also in the expression of mce1 operon in M. 
tuberculosis cells grown in synthetic medium.
Conclusion: The mce operon of M.tuberculosis H37Rv potentially can be transcribed from two promoters P1 and P2, 
former mapping upstream of Rv0166 and the latter in the non-coding intergenic region between Rv0166 and Rv0167. 
The transcription initiation from P1 results in a transcript with Rv0166 while that from P2 will be without it. The 
sequences between the translation start site of Rv0167 and the promoter P2 have a negative regulatory role, as point 
mutation within the sequence leads to enhanced activity of P2 as well as a heterologous promoter from M.smegmatis. 
The mutation detected in the clinical isolate VPCI591 therefore behaves like a gain-of-function mutation.
Background
Tuberculosis causes approximately two million deaths
annually and it has been estimated that around two bil-
lion people are currently infected with the causative
organism,  Mycobacterium tuberculosis [1]. Attempts to
understand the molecular basis of pathogenesis in tuber-
culosis include the analysis of genes involved in the entry
of the bacillus following the initial identification of mam-
malian cell entry protein, Mce1A by Arruda et al. [2].
Subsequent whole genome analysis revealed the presence
of four mce operons in M.tuberculosis H37Rv, consisting
of eight genes with extensive similarity between each
other [2,3]. Recently, Casali et al. [4] redefined the bound-
aries of mce1 making it an operon of 13 genes extending
from Rv0166 to Rv0178. The importance of mce operons
in virulence is illustrated by various phenotypes observed
in knock-out strains and the expression profile of the
operons in bacilli in culture and during infection [5-8].
The conservation of most of the mce  operons in all
members of the Mycobacterium tuberculosis complex,
and the presence of orthologous mce genes throughout
the genus Mycobacteria, including the non-pathogenic
species  M.smegmatis  suggests their functional impor-
tance in processes besides pathogenicity [6,7,9-13]. Casali
et al. [4] discovered that fadD5 gene (Rv0166) is also a
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part of the mce1 operon, adding to the probable func-
tional diversity of mce operons.
In tune with the proposed functional diversity it has
been suggested that mce1 operon could be under the con-
trol of a global stress regulator or multiple negative regu-
lators [4,14]. Rv0165c, a homologue of GntR regulator of
mce1 operon and Rv1963 a TetR family regulator of mce3
operon are characterized as negative regulators of the
respective operons [4,14,15]. The poor consensus of the
promoter sequence of mce3 operon at -10 and -35 posi-
tions is speculated to reflect the complex regulation of
the operon and its ability to interact with multiple sigma
factors [4]. Given the importance of mce1 operon and evi-
dences from knock-out studies, any alteration in the
expression or genetic polymorphism in mce  operons
would have significant consequence on the pathogenicity
and the severity of infection [6-8,16,17].
Here we examine the function of the non-coding
sequence between Rv0166 and Rv0167, which led us to
detect both promoter and negative regulatory element
within the sequence. A point mutation in the regulatory
region abolishes the negative regulation resulting in
enhanced promoter activity.
Results
Detection of a putative promoter in intergenic region of 
mce1 operon
ORF analysis on sequences extending from Rv0166
(nucleotide 194993-196657) across Rv0167 (nucleotide
196861-197658) revealed the expected stop codon for
Rv0166 at 196655 and the initiator codon for Rv0167 at
196861. However, no initiator codon was detected in the
200 base pairs between Rv0166 and Rv0167. This region
therefore appears to be non-protein coding sequence
within the mce1  operon in M.tuberculosis H37Rv. We
examined this sequence for probable promoter signature
by in silico analysis. We retrieved 10 sequences with dem-
onstrated promoter activity [18] in addition to the inter-
genic sequence of mce1 operon and aligned them with
reference to the translational initiation site of the respec-
tive gene. The presence of consensus motif was analyzed
using MEME http://meme.nbcr.net/meme3/meme.html.
Two motifs GGTT [CG] [CG]T and TT [AT] [TC] [CT]
[GA] [ACG]C were identified (p value > 1.31-e04) and
both the motifs are present in the non-coding intergenic
region between Rv0166 and Rv0167 of mce1 operon (Fig-
ure 1C &1D and Additional file 1). Since we detect land-
marks of promoters known in M.tuberculosis within this
region, we refer to it, henceforth as intergenic promoter
(IGPr). We undertook the functional characterization of
the predicted promoter activity of IGPr. We analyzed the
effect of a point mutation in the IGPr, detected in a multi-
drug resistant clinical isolate, VPCI591, under an inde-
pendent analysis of genetic polymorphism in mce oper-
ons of clinical isolates of M.tuberculosis (unpublished).
Promoter Activity of IGPr
A 200 bp fragment containing IGPr sequence was ampli-
fied from M.tuberculosis H37Rv and cloned in promoter-
less shuttle vector pSD5B, upstream of the lacZ as the
reporter gene to generate pPrRv. Similarly 200 bp frag-
ment from VPCI591 was cloned to produce pPr591 and
both were tested for promoter activity in M.smegmatis.
Different constructs used in the study are shown in Fig-
ure 2. Since a repression of mce1 operon at stationary
phase was reported earlier [5], we analyzed the promoter
activity of the two constructs both at log and stationary
phase of growth, by ONPG assay using cell-free extracts
from transformed M.smegmatis cells (Figure 3). The dif-
ference in the promoter activity of IGPr from VPCI591
(pPr591) is higher than that from M.tuberculosis H37Rv
(pPrRv) by 12 fold (1025 vs 85 units of β-galactosidase
activity) in log phase, which reaches 18 fold (2265 vs 130
units) in stationary phase (Figure 3). By comparing IGPr
with previously characterized weak (pSD5WP) and
strong (pSD5SP) promoters from M.tuberculosis [19], we
find that pPrRv is a weak promoter while pPr591 acts as a
strong promoter.
Deletion analysis of IGPr region
In order to delineate the region of promoter activity
within the 200 base pairs of IGPr , we made a series of
deletion constructs. We generated amplicons corre-
sponding to (-50 to +1), (-100 to +1), (-150 to-50) and (-
200 to -100) and cloned them in pSD5B for expression in
M.smegmatis  (Figure 2). The promoter activity of 200
base pairs from M.tuberculosis H37Rv (pPrRv) is very low
compared to that of the same region from VPCI591
(pPr591); 130 vs 2265 units respectively. The promoter
activity is highest when -100 to +1 is deleted (pPrD) both
in log (2255 units) and stationary phase of growth (4961
units, Figure 3); while it is negligible, when -200 to-100 is
deleted (pPrB591; 52 and 89 units in log and stationary
phase respectively). Additionally, the fragment containing
only -150 to -100 (pPrC591) shows poor activity. There-
fore we conclude that the promoter activity is restricted
to around 50 base pairs from -200 to -150 within IGPr
(Figure 3). Interestingly, significant promoter activity is
detected in the construct that is deleted for -100 to +1
(pPrD). These results suggest that -100 to +1 region
cloned in pPrRv has a negative effect which is lost in
pPr591 derived from the clinical isolate VPCI591. We
correlate this gain of expression due to loss of repression
to the presence of a point mutation (G > C) at -61 in
VPCI591.
To compare the mRNA levels from the two constructs,
we isolated total RNA from M.smegmatis  transformedJoon et al. BMC Microbiology 2010, 10:128
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with pPrRv (200 base pairs from M.tuberculosis H37Rv)
and pPr591 (200 base pairs from VPCI591) and the tran-
script level was estimated by quantitative PCR with lacZ
as target gene and sigA as the endogenous control in log
and stationary phase. At log phase there is nearly two fold
increase in lacZ transcripts in pPr591 as compared to
pPrRv whereas in stationary phase it is more than four
fold (Figure 4). The correlation between β-galactosidase
activity and the mRNA levels of lacZ  clearly indicate
greater transcriptional activity in pPr591 than pPrRv. The
difference in enzyme activity is much higher than the dif-
ference in mRNA levels as known in other cases [20-22].
Mapping the transcription start site in M.tuberculosis
We identified transcription start site of Rv0166 and
Rv0167  in vivo in  M.tuberculosis  H37Rv and VPCI591
using fluorescence tagged primers in primer extension
assay using RNA templates. The absence of DNA con-
tamination in RNA preparation was confirmed by PCR
for Rv0166 and Rv0167 in absence of reverse tran-
scriptase (data not shown). The sizing of the products
was carried out by genescan analysis and the TSS was
detected at -65 position from the translation initiation
site of Rv0166 and at -56 position from the translation
initiation site of Rv0167 (Figure 5B-E), suggesting that
there are two potential promoters for mce1 operon gener-
Figure 1 Diagrammatic representation of intergenic region of mce1 operon. (A)- Representation of the relative position of mce1 operon genes 
(within rectangles) in M.tuberculosis. Numbers above indicate the translational start site of the genes, arrows indicate the direction of transcription, 
filled bars indicate the intergenic regions. Figure is not drawn to scale. (B)- Mapping of the consensus motifs detected by MEME analysis of the pre-
dicted promoter sequences (IGPr). The motifs are highlighted in bold upper case. ATG is the translational start codon of Rv0167. (C, D)- Sequence logos 
of the two consensus sequences as given as the probability of occurrence at the given position with in the motif by the MEME software. The size of 
the letter indicating the strength of the consensus in the set of sequences analysed.Joon et al. BMC Microbiology 2010, 10:128
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ating two transcripts, one including Rv0166 and the other
without it (Figure 5A). Further, this demonstrated that
both promoters are active in the genomic context of
M.tuberculosis. Considering the translation initiation site
of Rv0167 as +1, we map the transcription start site
within IGPr at -56 position and the mutation in VPCI591
at -61 position.
Estimation of mce1 operon transcript levels in 
M.tuberculosis
The transcript level of Rv0167, Rv0170 and Rv0174 of
mce1 operon downstream to IGPr in M.tuberculosis and
VPCI591 was analyzed by quantitative PCR with rpoB as
the endogenous control (Figure 6A). The data reveals 1.5
fold upregulation of the mce1 operon genes in VPCI591
as compared to M.tuberculosis H37Rv (Figure 6B). The
difference at protein level is considerably higher than at
the transcript levels in case of β-galactosidase, similar
enhancement in Mce1 protein levels could also be antici-
pated.
Effect of the regulatory sequence of IGPr on heterologous 
promoter
To examine if the negative regulatory site, -100 to +1
region of IGPr functions independent of the associated
promoter activity, we cloned it downstream of a heterolo-
Figure 2 Delineation of regulatory region. Deletion constructs were generated to segregate promoter and the regulatory regions of IGPr. The col-
umn labeled as construct shows configuration of the inserts in different clones used in transformation of M.smegmatis mc2 155. The numbering is with 
reference to the translational initiation signal for Rv0167 as +1. The mutation in VPCI591 is shown as a filled triangle, the regions deleted in each clone 
is indicated by delta symbol. IGPr: 200 bp intergenic region between Rv0166 and Rv0167.Joon et al. BMC Microbiology 2010, 10:128
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gous promoter in pSdps1, driving the expression of β-
galactosidase [23]. pSdps1 has 1 kb upstream region of
the gene MSMEG_6467 from M.smegmatis. The pro-
moter in pSdps1 is inducible under glucose starvation; at
0.02% glucose in Middlebrook 7H9 liquid medium in sta-
tionary phase [23]. By inclusion of +1 to -100 from IGPr
of H37Rv (pDPrBRv) the promoter activity decreased by
35% relative to the control plasmid pSdps1 (895 versus
1358 units, Figure 7). When +1 to -100 from VPCI591
was cloned downstream to dps promoter (pDPrB591), the
repression was reversed and the promoter activity was
enhanced by 25% over that of pSdps1 (1709 versus 1358
units). This shows that negative regulation by IGPr func-
tions in the context of a heterologous promoter also.
Discussion
The mce1 operon is different from other three mce oper-
ons in having Rv0166, a fatty acyl CoA synthetase that
catalyzes the initial step in lipid degradation [4,24]. On
the other hand, mce4 operon is known to be a part of the
regulon involved in cholesterol metabolism, however it
seems to be just one of the many possible lipid substrates.
Furthermore, it is speculated that mce1 operon may not
have a role in cholesterol import as the loss of Mce1
transporter system does not appear to affect the residual
uptake of cholesterol in mce4- deficient strain [25].
The presence of 200 base pairs of non-coding sequence
between Rv0166 and Rv0167 is yet another feature pecu-
liar to mce1 operon among the other four operons pres-
ent in M.tuberculosis. In most other operons and also the
other genes within mce1 operon, the intergenic distance
is not more than one or two codons and often the transla-
tion initiation site of one gene is within the coding
sequence of the adjacent gene [12]. In silico analysis using
GeneRunner software shows the absence of any ORFs in
the intergenic region between Rv0166 and Rv0167, while
ribosomal binding site corresponding to the translational
start site of Rv0167 is reported in Tuberculist database.
Although most prokaryotes do not have introns, the
intergenic region in transcripts serve as substrates for
several endonucleases such as RNaseP involved in mRNA
processing and hence are implicated in the regulation of
gene expression [26-29].
We have characterized the promoter and negative regu-
latory activity in the surrogate host M.smegmatis, but the
detection of two active transcription initiation sites both
in M.tuberculosis H37Rv and VPCI591 suggests both pro-
moters are functional in their native context also.
However the increased promoter strength of the regu-
latory region from VPCI591 in M.smegmatis  is not
reflected in the difference in the transcript levels for mce1
operon genes in VPCI591 as compared to M.tuberculosis
H37Rv. This may have two reasons, one that both P1 and
P2 promoters are active in vivo and therefore contribute
to the transcript levels in both the strains, while in
M.smegmatis we observe a clear upregulation of P2 when
the negative regulation is lost due to point mutation and
P1 is absent (since only P2 is cloned in the plasmid). Fur-
ther, the difference in fold increase in β-galactosidase
activity vis-ΰ-vis its transcript levels are significantly dif-
ferent. Similar discordance between protein and mRNA
levels is reported in Mycobacteria and S.cerevisiae [20-
22]. Moreover, in vivo mce1 operon could be under the
regulatory influence of several factors acting directly or
indirectly [4].
We looked for concordance in the expression level of
Rv0166 and 0167, as polycistronic mRNA including
Rv0166 in M.tuberculosis is reported by Casali et al. [4].
Figure 3 Promoter Activity of IGPr deletion constructs. β-galacto-
sidase activity is expressed as nanomoles of ONPG converted to o-ni-
trophenol per min per mg of protein for the constructs. Each 
experiment was carried out in triplicates and standard deviation is in-
dicated by error bars. The hatched and crossed bars represent log and 
stationary phase respectively. Please see Figure 2 for description of 
constructs used.
Figure 4 Quantitative PCR analysis of LacZ reporter gene. Fold dif-
ference in transcript level in pPr591 over that of pPrRv in log phase and 
stationary phase cultures are shown. The fold difference observed is 
the average of three independent experiments. Error bars represent 
the standard deviation.Joon et al. BMC Microbiology 2010, 10:128
http://www.biomedcentral.com/1471-2180/10/128
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For comparison, we examined the expression of pairs of
adjacent genes in five different operons including Rv1964
and Rv1965 of mce 3 operon, Rv2498c and Rv2499c of
CitE-scoA operon along with that of Rv0166 and Rv0167
of mce1 operon. The expression data was taken from pub-
lished microarray profiles of M.tuberculosis H37Rv cells
grown in culture [30]. Pearson's correlation coefficient in
the range of 0.8 to 0.58 is observed in all cases except
Rv0166 and Rv0167 of mce1 operon [0.24; Additional file
2]. Similar difference between coefficient of correlation
Figure 5 Mapping of transcription start site (TSS) in mce1 operon. A -Line diagram indicating the position of primers used for mapping TSS by 
primer extension. The numbers in parenthesis indicate the map position on the reference sequence of M.tubersulosis H37Rv. Filled boxes indicate non-
coding regions, filled arrowheads indicate translation start site, tsp1 is HEX-labeled primer beginning at 195092, tsp2 is FAM-labeled primer beginning 
at 196960. P1 and P2 represent the TSS detected. B-E show Genescan analysis of the products of primer extension reactions on mRNA from M.tuber-
culosis H37Rv (B, D) and VPCI591 (C, E) with fluorescence labeled primers is shown in A. The peak at 165 bp position is transcript from P1 promoter and 
the peak at 156 position transcript from P2 promoter.Joon et al. BMC Microbiology 2010, 10:128
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was observed when we considered the data from clinical
isolates grown in Middlebrook 7H9 medium [31]. These
results imply that the transcript level is lower for Rv0166
compared to Rv0167, as Rv0166 can be transcribed only
from P1 while Rv0167 can be transcribed from both P1
and P2 promoters. Thus lending support to our data sug-
gesting that both promoters of mce1 operon are active in
cells in culture.
Though M. tuberculosis system is replete with examples
where the expression of an operon is driven by multiple
promoters [32-34], the promoters are known to drive the
expression of all the genes of the operon. A study on
furA-katG  region shows differential regulation of two
katG  promoters resulting in two different transcripts
depending on the stage of infection of Mycobacterium
tuberculosis  [35]. However the consequences of tran-
scription from intergenic promoter could be different. It
can only be speculated that two different polycistronic
mRNA varying in coding capacity for a catalytic function
can be produced by mce1 operon: one that includes fatty
acyl-CoA synthase (Rv0166) and other lacking it, in
absence of in vivo infection data. This suggests the possi-
ble modulation of the function of mce1 operon in cell
entry and lipid metabolism vis-ΰ-vis its catalytic function.
However, it remains to be examined if the intergenic pro-
moter/regulatory region in mce1  operon could bring
about differential regulation during infection.
The mce1 and mce2 operons are known to be negatively
regulated by divergently transcribed genes mapping
immediately upstream of the operon [4,36]. Though
Mce1R, the product of Rv0165c is characterized as a neg-
ative regulator of mce1  operon, its binding site is not
deciphered so far. The results of Casali et al. [4] suggest
that the site of interaction of Mce1R is in a region
upstream of Rv0166, while the negative regulatory ele-
ment we have identified is downstream to Rv0166. Fur-
ther we failed to detect direct binding of intergenic
promoter with purified His-tagged Rv0165c cloned in
pET-28a in gel-shift assays even at high molar ratio of
protein to DNA (2000:1). Therefore, it appears that mce1
operon has more than one negative regulator. However, it
is interesting to note that a heterologous promoter in
pSdps1 is also down regulated by the regulatory region of
-100 to +1 fragment of IGPr, thus demonstrating that the
100 bp fragment is necessary and sufficient for repressive
activity.
Casali et al. [4] also observed that mce1 operon can be
repressed independent of Mce1R by incubation in
DMEM medium and suggest that mce1 operon may be
under multiple negative regulators. Based on their study
on lipid degradation operon Kendall et al. [24] observed
that operon regulation may be more complex than one
would expect for a prokaryotic system and may not be
guided by just a single regulator.
Conclusions
Our data strongly supports the presence of two func-
tional promoters for mce1 operon in M.tuberculosis that
could potentially segregate different functions of a single
operon. Our results demarcating the regulatory
sequences in the intergenic region of mce1 operon pro-
vide a handle for identifying interacting factors and
studying the implications of derepression in the clinical
isolate.
Figure 6 Quantitative PCR analysis of mce1 operon in M.tubercu-
losis H37Rv and VPCI591. (A)- Diagrammatic representation [not to 
scale] of the mce1 operon. Arrows indicate the position of primers. The 
hatched box depicts IGPr region. (B)- Fold difference in transcript level 
in VPCI591 over that of M.tuberculosis H37Rv for Rv0167, Rv0170 and 
Rv0174 in log phase (dotted) and stationary phase (hatched). The fold 
difference observed is the average of three independent experiments. 
Error bars represent the standard deviation.
Figure 7 Regulation of heterologous promoter by IGPr. dps pro-
moter activity under induced conditions in different constructs in 
terms of β-gal activity units expressed as nmol ONPG converted to o-
nitrophenol per min per milligram of protein. The transformants were 
grown in Middlebrook 7H9 medium supplemented with 0.02% glu-
cose (Induced). Each experiment was carried out in triplicates and S.D 
is indicated as error bars.Joon et al. BMC Microbiology 2010, 10:128
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Methods
In silico analysis
The non-coding sequence was detected through ORF
analysis of mce1 operon using Gene Runner Version 3.01
available at http://www.generunner.net. To identify pro-
moter-like sequences in the intergenic region, the 200
base pair sequence between Rv0166 and Rv0167 was
aligned with validated promoter sequences given by
Bashyam et al. [18]. The presence of a consensus motif
was analysed using the MEME program http://
meme.nbcr.net/meme3/meme.html available in the pub-
lic domain [37].
Enzymes and Chemicals
Restriction enzymes, T4 DNA ligase, RNase free DNaseI
were purchased from MBI Fermentas. Kanamycin was
from Himedia laboratories Pvt. Ltd., India. The reagents
for competent cell preparation, transformation, reporter
assays were obtained from Sigma laboratories, USA. [γ-32
P] ATP was from Board of Radiation and Isotope Tech-
nology, India.
Bacterial strains and culture conditions
All the strains and plasmid constructs used in the present
study are described in Additional file 3. M.smegmatis
mc2155  (ATCC 700084) was obtained from Dr. Anil
Tyagi, South Campus, University of Delhi and Mycobac-
terium tuberculosis H37Rv were obtained from Central
Jalma Institute for leprosy, Agra, India; Mycobacterium
tuberculosis VPCI591 is a clinical isolate from Vallabhb-
hai Patel Chest Institute; Delhi. M.tuberculosis  strains
were grown in Middlebrook 7H9 broth supplemented
with OADC (Oleic acid, Bovine albumin fraction V, dex-
trose-catalase) from Difco laboratories, USA and 0.05%
Tween 80 (Sigma). M.smegmatis  was grown either in
Middlebrook 7H9 supplemented with glycerol or on Mid-
dlebrook 7H11 plates. Middlebrook 7H9 medium was
supplemented with appropriate concentration of glucose
whenever M.smegmatis clones with dps promoter were
grown, as specified in the results section. Cloning was
carried out in Escherichia coli DH5α (Stratagene) grown
in Luria-Bertani medium (Difco laboratories, USA).
Kanamycin (20 μg/ml) was included for maintenance of
plasmids. Transformation in Escherichia coli DH5α was
carried out using heat shock method [14] and in M. smeg-
matis mc2155 by electroporation [19] using Gene Pulser
(Bio Rad Laboratories Inc. Richmond, California) at 2.5
kV, 25 μF and 1000 Ù in 0.2 cm gap electroporation
cuvettes.
The primers used are listed in Additional file 4. The
intergenic region of Rv0166-Rv0167 was PCR amplified
using primers Mce1AF and Mce1AR from genomic DNA
of  Mycobacterium tuberculosis H37Rv and the clinical
isolate VPCI591, cloned in XbaI-SphI sites of pSD5B
[Additional file 4, [38]]. Deletion constructs were created
by PCR amplification of selected region with specific
primers followed by cloning in XbaI-SphI sites of pSD5B.
Fragment corresponding to +1 to -100 region of inter-
genic promoter region (IGPr) was amplified from both
M.tuberculosis H37Rv and VPCI591 strain, cloned in the
vector pSdps1 downstream of glucose regulated dps pro-
moter [23,39] to generate pDPrBRv and pDPrB591
respectively at VspI-PstI site and electroporated into M.
smegmatis mc2155. pSdps1 has 1 kb upstream region of
dps  gene (MSMEG_6467, DNA binding protein from
starved cells) from M. smegmatis. The transformants
were screened by PCR, confirmed by restriction digestion
and sequencing.
The expression of β-galactosidase was assayed both in
the log (O.D.600 0.8) and stationary phase (O.D.600 2.0) cul-
tures of the transformants using modified protocol of
Miller et al. [40]. Promoter activity is expressed as units
of β-galactosidase activity in terms of ONPG converted
to o-nitrophenol (nmol per min per mg of protein).
Mapping transcription start site
The transcription start site was mapped using the strat-
egy described by Lloyd et al. [41]. Primer extension was
carried out on DNA free RNA with fluorescence labeled
primers HEX-tsp1 and FAM-tsp2 mapping 100 nucle-
otides downstream of the translation initiation site of
Rv0166 and Rv0167 respectively [Additional file 4]. The
DNA sequence analysis and Genescan analysis was car-
ried out at the commercial facility of The Centre for
Genomic Application, Okhla, New Delhi and Labindia,
Udyog Vihar, Gurgaon, India respectively. The Genescan
analysis was carried out on 3130×l Genetic Analyzer
from Applied Biosystems with GSLIZ 500 as marker set.
The data was analyzed using GeneMapper V4.0.
Quantitative RT-PCR
The transcriptional activity in log and stationary phase,
was estimated by quantitative PCR using cDNA samples.
15 ml cultures of M.tuberculosis  H37Rv and VPCI591
from log (day10) and stationary phase (day 20) were har-
vested at 4°C. RNA isolation was performed using
RNeasy Mini Kit (Qiagen) and treated with DNaseI (MBI
Fermentas). Absence of amplicons in PCR without
reverse transcriptase confirmed the absence of DNA con-
tamination. 500 ng of DNase I treated total RNA samples
extracted were retrotranscribed using cDNA synthesis kit
( M B I  F e r m e n t a s )  w i t h  r a n d o m  h e x a m e r  p r i m e r s .  R e a l
Time PCR was performed using SYBR Green PCR master
mix (Applied Biosystems, USA); sigA or rpoB was used as
endogenous control. The relative expression of mce1
operon genes (Rv0167, Rv0170 and Rv0178) in M.tuber-
culosis H37Rv and VPCI591 and lacZ expression from
the clones pPrRv and pPr591 in M.smegmatis was deter-Joon et al. BMC Microbiology 2010, 10:128
http://www.biomedcentral.com/1471-2180/10/128
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mined, using similar protocol. The experiments were
repeated three times and the data was analyzed using the
ΔΔCt method [42].
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